Daewoong Pharmaceutical Establishes Advanced Biopharmaceutical Manufacturing Facility in Songdo

Full-scale Operations to Begin After Regulatory Approval Within This Year

“Building Clinical Research Infrastructure Linking Yongin and Songdo”

On September 29, Daewoong Pharmaceutical announced the establishment of a new Advanced Biopharmaceutical Manufacturing Facility in Songdo, Incheon.

Located within the Yonsei University International Campus, the bio-manufacturing facility is equipped with global-standard aseptic manufacturing and quality control systems. It will produce clinical trial stem cell and immune cell products. Daewoong Pharmaceutical plans to complete the legal approval process for the manufacturing and processing of advanced biopharmaceuticals within this year and begin full-scale operations.

Sungsoo Park, CEO of Daewoong Pharmaceutical, is presenting the vision and future plans for the Songdo hub at the opening ceremony of the advanced biopharmaceutical manufacturing facility held on the 28th in Songdo, Incheon. Daewoong Pharmaceutical

The establishment of the Songdo manufacturing facility aims to bridge the company’s accumulated research achievements to clinical application and to secure a stable production base for advanced bio materials required for clinical studies. The company plans to further strengthen its domestic presence and expand its global bio network encompassing research, clinical trials, and production by linking the Songdo hub with overseas sites such as Indonesia.

Additionally, Daewoong Pharmaceutical will expand open innovation collaboration with universities, research institutes, and medical institutions in the region, promoting industry-academia-research-hospital cooperation. The company also plans to build an advanced regenerative medicine ecosystem, where research accomplishments can be translated into actual clinical applications and treatments.

Sungsoo Park, CEO of Daewoong Pharmaceutical, said, "Based on our clinical research infrastructure connecting Yongin and Songdo, we will collaborate with outstanding researchers and key medical institutions to grow together with the bio ecosystem."

This content was produced with the assistance of AI translation services.